Hexagon Nutrition promoter Dr. Nikhil Kelkar acquires 10,000 shares

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Dr. Nikhil Kelkar acquired 10,000 equity shares in Hexagon Nutrition via open market
  • Transaction date was September 16, 2026
  • Promoter's stake increased from 17.27% to 17.28%
  • Total holding now stands at 2,12,42,468 shares
  • Disclosure filed under SEBI SAST Regulation 29(2)
powered bylight_fuzz_icon
51260074

*this image is generated using AI for illustrative purposes only.

Dr. Nikhil Kelkar, Joint Managing Director of Hexagon Nutrition , acquired 10,000 equity shares in the company through open market transactions on September 16, 2026. The acquisition increases his total holding to 2,12,42,468 shares.

The purchase was disclosed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The filing was submitted to the National Stock Exchange of India Limited and BSE Limited on September 17, 2026.

Holding Details

Prior to this transaction, Dr. Kelkar held 2,12,32,468 shares, representing 17.27% of the total voting capital. None of these shares were encumbered by pledge or lien.

Metric Before Acquisition After Acquisition
Shares Held 2,12,32,468 2,12,42,468
Stake Percentage 17.27% 17.28%

The post-acquisition holding stands at 17.28% of the total share capital. The total diluted share/voting capital of the target company remains unchanged at 12,29,18,109 shares.

Historical Stock Returns for Hexagon Nutrition

1 Day5 Days1 Month6 Months1 Year5 Years
+1.88%-3.92%+3.56%+45.56%+45.56%+45.56%

Does this incremental stake acquisition signal Dr. Kelkar's confidence in Hexagon Nutrition's upcoming financial performance or potential strategic initiatives?

How might this increased insider ownership influence retail investor sentiment and short-term trading volume in the stock?

Are there indications that this purchase is part of a broader pattern of insider buying within the executive team, suggesting unified bullishness on the company's prospects?

Hexagon Nutrition FY26 PAT surges 56% to ₹379 million; AGM on Sep 22

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Consolidated PAT surged 56% YoY to ₹379.37 million in FY26, outpacing 17.8% revenue growth
  • EBITDA margin expanded by 150 bps to 13.8%, reflecting improved operational efficiency
  • Branded nutrition segment crossed ₹1,000 million mark with 23.74% YoY growth
  • Company scheduled 33rd AGM for September 22, 2026, recommending ₹0.30 per share final dividend
  • Web-links for Integrated Annual Report distributed to members without registered emails
powered bylight_fuzz_icon
49742544

*this image is generated using AI for illustrative purposes only.

Hexagon Nutrition has scheduled its 33rd Annual General Meeting for September 22, 2026, alongside reporting its strongest-ever financial performance for FY2025-26, with consolidated profit after tax rising 56% year-on-year to ₹379.37 million.

The company has also intimated the distribution of web-links for its Integrated Annual Report to members without registered email addresses, ensuring access to the notice convening the AGM and the annual report for FY26.

FY26 Financial Highlights

The company's consolidated revenue from operations grew 17.8% year-on-year to ₹3,826.28 million in FY2025-26, compared to ₹3,249.29 million in FY2024-25. Profitability expanded well ahead of revenue, with EBITDA rising 32.0% to ₹529 million and EBITDA margin widening to 13.8% from 12.3% in the prior year. PAT margin improved to 9.9% from 7.5%.

Metric FY2025-26 FY2024-25 Change
Revenue from Operations (₹ mn) 3,826.28 3,249.29 +17.8%
EBITDA (₹ mn) 529 401 +32.0%
EBITDA Margin (%) 13.8 12.3 +150 bps
Profit After Tax (₹ mn) 379.37 243.05 +56.1%
PAT Margin (%) 9.9 7.5 +240 bps
Basic EPS (₹) 3.43 1.75 +96.0%
Return on Equity (%) 17.8 10.8 +700 bps
Net Debt/Equity (times) 0.13 0.14 —

On a standalone basis, revenue from operations stood at ₹3,191.20 million versus ₹2,674.47 million in FY2024-25, with standalone PAT at ₹381.48 million compared to ₹269.69 million.

Segment Performance

The company operates across three segments. The branded nutrition (B2C) segment delivered year-on-year growth of 23.74%, crossing the ₹1,000 million mark. The premix formulations (B2B2C) segment grew 31% overall, with domestic premix up 44.06% and export premix up 24.87%. The ESG segment declined 16.51% due to delays in tender releases.

Segment Revenue (₹ mn) Share (%)
Branded Nutrition (B2C) 1,139.56 30
Premix Formulations (B2B2C) 2,026.48 53
ESG Segment 649.95 17

Export revenue contributed approximately 57% of total FY26 revenue, with the company exporting to 80+ countries across five continents.

IPO Listing and Corporate Developments

Hexagon Nutrition listed on the NSE and BSE on June 12, 2026, through a 100% Offer for Sale of 3,08,59,704 equity shares at an issue price of ₹45 per share, aggregating to ₹138.87 crore. The IPO was subscribed 53.68 times overall, with the QIB portion subscribed 19.77 times, NII 161.49 times, and retail 26.85 times. The listing price was ₹48.25 per share on NSE and ₹48.00 per share on BSE.

During the year, Hexagon Nutrition (Exports) Private Limited was amalgamated with the company pursuant to an NCLT order dated January 14, 2026, with an appointed date of April 1, 2025.

Dividend and AGM Agenda

The Board has recommended a final dividend of ₹0.30 per equity share of face value ₹1 each for FY2025-26, subject to shareholder approval at the AGM. The record date for dividend eligibility is September 15, 2026, and the dividend payment date is between September 23, 2026 and October 22, 2026.

The 33rd AGM will be held on Tuesday, September 22, 2026 at 11:30 am (IST) through video conferencing. Key resolutions include adoption of financial statements, re-appointment of Dr. Nikhil Arun Kelkar as Joint Managing Director, declaration of the final dividend, appointment of Raghunath Sawant as Executive Director, revision in remuneration of executive directors, and alteration of the Articles of Association.

AGM Detail Particulars
Date September 22, 2026
Time 11:30 am IST
Mode Video Conferencing / OAVM
Record Date September 15, 2026
Remote e-Voting Period September 19, 2026 (9:00 am) to September 21, 2026 (5:00 pm)

Members who have not registered their email addresses can access the Annual Report and AGM Notice via the web-link provided by the company. The exact path is Investors → Annual Report → Hexagon Nutrition Limited → Annual Report 2025-26 on the company website.

Key Financial Ratios

Ratio FY2025-26 FY2024-25
Current Ratio (times) 3.38 3.50
Return on Capital Employed (%) 20.9 17.1
Net Worth (₹ mn) 2,333 1,942
Debt Service Coverage Ratio 1.89 1.52

The company's R&D expenditure for FY26 stood at ₹18.35 million. Foreign exchange inflows were ₹1,498.79 million and outflows were ₹660.91 million during the year.

Historical Stock Returns for Hexagon Nutrition

1 Day5 Days1 Month6 Months1 Year5 Years
+1.88%-3.92%+3.56%+45.56%+45.56%+45.56%

How might the 16.51% decline in the ESG segment impact Hexagon Nutrition's overall growth trajectory once government tender delays are resolved?

Given that exports constitute 57% of revenue, what hedging strategies is the company employing to mitigate currency fluctuation risks in its top export markets?

Will the proposed revision in executive director remuneration align with performance metrics tied to the recent 56% PAT surge, and how will shareholders react?

More News on Hexagon Nutrition

1 Year Returns:+45.56%